Chiasma, Inc. (CHMA) Announces Additional 44% Workforce Reduction
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- Wall St ends higher on cool inflation data, strong earnings
- U.S. headline producer inflation posts first one-month decrease since August 2025
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices make small gain on smaller US inventory draw
- ASML capacity upgrade soothes AI chip bottleneck fears
Chiasma Announces Workforce Reduction
August 16, 2016 9:02 AM EDTWALTHAM, Mass., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today announced that it is further reducing its workforce by approximately 44%, primarily in the companys research and general and administrative functions, to lower its operating expenses and extend its cash runway. Â This action follows Chiasmas announcement of a corporate restructuring plan in June 2016, which included an initial workforce reduction composed primarily of the companys commercial personnel. Â Chiasma intends to focus its resources on the continued... More
